Ready Capital RC Q1 2026 Earnings Transcript

Ready Capital reported a Q1 GAAP loss of $1.25 per share and a distributable loss of $1.00 per share, while book value fell to $7.43 from $8.79 at year-end. Management is still in a multi-quarter deleveraging and asset-sale transition, with $1.4 billion of cash generated year-to-date, but recurring revenue dropped to $16.2 million from $41.5 million and leverage remained elevated at 3.0x. The company expects another $2.0 billion-$2.5 billion of CRE loan and REO reductions and sees leverage stabilizing around 2.5x, but net interest income is expected to stay negative during the reset.

Analysis

The cleanest read is that the company is in a forced de-risking phase, and the market should treat the next two quarters as a balance-sheet event rather than an earnings event. The important second-order effect is that every dollar of asset sales now has a double cost: it shrinks earning assets while also forcing realized marks and reserve builds before replacement capital is redeployed. That means headline book value pressure can persist even as liquidity improves, creating a classic "good balance sheet, bad income statement" setup that often keeps the equity cheap until the transition is visibly complete.

The more interesting upside is not in the legacy CRE book; it is in the optionality created by freeing capacity for SBA and fee-generating origination. If management can actually restart originations at the implied scale, the earnings mix should move from spread-dependent to fee-plus-distributed-ROE, which is meaningfully more resilient to funding costs. The key swing factor is timing: if the securitization and warehouse capacity reset slip even one quarter, the negative carry from runoff and nonaccruals will likely overwhelm the small-business rebound narrative.

Credit investors may be the cleaner expression than equity here. The remaining 2026 bond overhang is small enough that execution risk is more about extension/mark-to-market than solvency, but the equity still has to absorb any mismatch between asset-sale pricing and reserve assumptions. The contrarian angle is that the market may be underestimating the value of the tax assets and the redeployed capital if the legacy pool is truly finite; however, that only matters if normalized profitability returns before the deferred tax asset becomes a capital trap.

Key Decisions for Investors

• Short RCB common into any relief rally over the next 2-6 weeks; the setup is still a transition story with negative NII and further book-value leakage before the reset is complete. Risk/reward is attractive if the stock re-rates on liquidity headlines without accompanying earnings stabilization.
• Prefer RCB bonds over equity for the next 3-9 months; the equity is absorbing execution risk while the remaining maturities appear manageable if the liquidity plan stays on schedule. Use the capital structure as a cleaner way to express near-term deleveraging.
• If we want upside optionality, buy 3-6 month call spreads only after the next asset-sale milestone is confirmed; the catalyst is completion of the remaining portfolio reduction, not the current quarter. Before that, theta likely dominates.
• Pair trade: long quality CRE lenders / short RCB equity for the next quarter, as the market may rotate toward names with stable NII and lower transition risk. This should work if asset-sale losses continue to pressure book value while peers benefit from cleaner balance sheets.
• Watch for a tactical long only if SBA securitization successfully restores originations and management proves fee income can offset runoff within 1-2 quarters. Without that proof, the rebound case remains conceptual rather than investable.